News & Perspective

Apr 20, 2020

Apr 20, 2020

News Scan for Apr 20, 2020

Flu research response plan
Targeted hygiene to reduce AMR
Antibiotic prophylaxis for C-sections

Mar 27, 2017

Mar 27, 2017

News Scan for Mar 27, 2017

MERS case
Avian flu in 3 nations
Meningitis in Nigeria
Preparedness spending

Sep 30, 2021

Sep 30, 2021
Flu vaccine researcher

WHO- and CIDRAP-led flu vaccine roadmap presents path to better vaccines

The 10-year plan starts today and gives recommendations for a range of scientific disciplines to better address seasonal flu and prepare for the next flu pandemic.

Jan 09, 2018

Jan 09, 2018
Surgical mask and hood

Experts decry lack of flu pandemic readiness, commitment

The Trump administration is making no effort to prioritize game-changing flu vaccines, the experts say.

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Jan 17, 2013

Jan 17, 2013

FDA approves first flu vaccine grown in insect cells

(CIDRAP News) – The US Food and Drug Administration (FDA) has approved the first influenza vaccine produced with the help of an insect virus and recombinant DNA technology, an approach the agency says may make it possible to start production faster in the event of a flu pandemic.

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Oct 15, 2012

Oct 15, 2012

Report: Complacency, misperception stymie quest for better flu vaccines

The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.

Oct 15, 2012

A game-changing approach to investigating flu vaccines

Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»